Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya

AIDS and Behavior

Volumn 16, Issue 5, 2012, Pages 1295-1307

  Hatcher, Abigail M ^a,b   Turan, Janet M ^a,c   Leslie, Hannah H ^d   Kanya, Lucy W ^e   Kwena, Zachary ^f   Johnson, Malory O ^b   Shade, Starley B ^b   Bukusi, Elizabeth A ^a,f   Doyen, Alexandre ^e   Cohen, Craig R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Vestergaard Frandsen   (Kenya)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Antiretroviral treatment; Community based testing; HIV counseling and testing; HIV 1; Linkage to care; Sub saharan africa; Survival analysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DIRECTIVE COUNSELING; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; KENYA; MALE; METHODOLOGY; MIDDLE AGED; NEEDS ASSESSMENT; PATIENT ATTITUDE; PATIENT REFERRAL; PSYCHOLOGICAL ASPECT; SELF DISCLOSURE; SELF REPORT; SEXUAL BEHAVIOR; STATISTICS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-HIV AGENTS; COHORT STUDIES; DIRECTIVE COUNSELING; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; KENYA; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PATIENT ACCEPTANCE OF HEALTH CARE; REFERRAL AND CONSULTATION; SELF DISCLOSURE; SELF REPORT; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84863724256     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0065-1     Document Type: Article

References (111)

1. Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008;10(371(9624)):1603-11. (Pubitemid 351626844)
2. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in highincome countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;26(9635):293-9.
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998; 26(338(13)):853-60. (Pubitemid 28135961)
4. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;11(367(9513)): 817-24.
5. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;1(22(15)): 1897-908.
6. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4\200 cells/microL) with HIV infection. HIV Med. 2004;5(2):93-8. (Pubitemid 38404662)
7. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001;5(15(1)):77-85. (Pubitemid 32055782)
8. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86(7):559-67. (Pubitemid 351931216)
9. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004; 9(18(6)):887-95. (Pubitemid 38553709)
10. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, et al. Rapid scaling-up of antiretroviral therapy in 10, 000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS. 2008;23(22(7)):873-82. (Pubitemid 351563837)
11. Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, et al. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microL is associated with improved treatment outcomes in South Africa. AIDS. 2010;24(24(13)): 2041-50.
12. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care. 2007;19(5):626-36. (Pubitemid 46763737)
13. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, et al. Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS. 2010; 24(17):2645.
14. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;30(360(18)): 1815-26.
15. Kigozi BK, Sumba S, Mudyope P, Namuddu B, Kalyango J, Karamagi C, et al. The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint. Clinical Research Centre, Uganda. AIDS Res Ther. 2009;6:17.
16. Murphy RA, Sunpath H, Taha B, Kappagoda S, Maphasa KT, Kuritzkes DR, et al. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2010;14(7):903-8.
17. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;16(296(7)):855-8. (Pubitemid 44223108)
18. Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;1(40(1)):96-101. (Pubitemid 41233212)
19. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(1):S3-S8. (Pubitemid 47312320)
20. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;17(23(11)): 1397-404.
21. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. Lancet. 2008;22(372(9652)):1806-7. author reply 1807.
22. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48-57.
23. Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, CoutinhoA, et al.The costs and effectiveness of fourHIVcounseling and testing strategies in Uganda. AIDS. 2009;28(23(3)):395-401.
24. Negin J, Wariero J, Mutuo P, Jan S, Pronyk P. Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health. 2009;14(8):849-55.
25. Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, et al. Removing barriers to knowing HIV status: mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr. 2006;1(41(2)):218-24.
26. Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, et al. Rapid implementation of an integrated largescale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010;5(8):e12435.
27. Grabbe KL, Menzies N, Taegtmeyer M, Emukule G, Angala P, Mwega I, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;1(54(3)): 317-23.
28. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS. 2010;24(11):735-41.
29. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch InternMed. 2008;9168(11): 1181-7. (Pubitemid 351831401)
30. Mugavero M, Lin H, Allison J, Willig J, Chang P, Marler M, et al. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis. 2007;45:127-30. (Pubitemid 46984628)
31. Reed JB, Hanson D, McNaghten AD, Bertolli J, Teshale E, Gardner L, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000-2004. AI DS Patient Care STDS. 2009;23(9):765-73.
32. Ohl M, Tate J, Duggal M, Skanderson M, Scotch M, Kaboli P, et al. Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection. Med Care. 2010;48(12):1064-70.
33. Tobias CR, Cunningham W, Cabral HD, Cunningham CO, Eldred L, Naar-King S, et al. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS. 2007;21(6):426-34. (Pubitemid 46988408)
34. Decroo T, Panunzi I, das Dores C, Maldonado F, Biot M, Ford N, et al. Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc. 2009;12(1):6.
35. Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa? not everyone who should. AIDS. 2010;24(Suppl 1):S37-S44.
36. Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20(2):146-9. (Pubitemid 351651266)
37. Wanyenze RK, Hahn JA, Liechty CA, Ragland K, Ronald A, Mayanja-Kizza H, et al. Linkage to HIV Care and survival following inpatient HIV counseling and testing. AIDS Behav. 2011;15(4):751-60.
38. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One. 2010;5(11):e13801.
39. Nakigozi G, Makumbi F, Reynolds S, Galiwango R, Kagaayi J, Nalugoda F, et al. Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda. AIDS Care. 2011;23(6):764-70.
40. Rosen S, Fox MP. Retention in HIV Care between testing and treatment in Sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056.
41. Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis. 2011;11(7):525-32. 3.
42. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health. 2008;17(1):47-55. (Pubitemid 351197536)
43. Amuyunzu-Nyamongo M, Okeng'o L, Wagura A, Mwenzwa E. Putting on a brave face: the experiences of women living with HIV and AIDS in informal settlements of Nairobi, Kenya. AIDS Care. 2007;19:S25-S34. (Pubitemid 46393112)
44. Bond V. Stigma when there is no other option: understanding how poverty fuels discrimination toward people living with HIV in Zambia. AIDS, Poverty, and Hunger. Washington: International Food Policy Research Insitute; 2006. p. 181-197.
45. Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters D, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. 2008;102(11):1067-74.
46. Mshana GH, Wamoyi J, Busza J, , B, Changalucha J, Kaluvya S, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006;20(9): 649-57.
47. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78-86.
48. Otieno PA, Kohler PK, Bosire RK, Brown ER, Macharia SW, John-Stewart GC. Determinants of failure to access care in mothers referred to HIV treatment programs in Nairobi, Kenya. AIDS Care. 2010;22(6):729-36.
49. Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008;13(7):904-13. (Pubitemid 351813518)
50. Marum E, Taegtmeyer M, Chebet K. Scale-up of voluntary HIV counseling and testing in Kenya. JAMA. 2006;16(296(7)): 859-62. (Pubitemid 44223109)
51. Mugavero MJ, Norton W, Saag. Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragmanets of a fractured health care delivery system. Clin Infect Dis. 2011;52((S2)):S238-46.
52. DiClemente RJ, Salazar LF, Crosby RA. A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach. J Pediatr Psychol. 2007;32(8):888-906. (Pubitemid 350194871)
53. Latkin CA, Knowlton AR. Micro-social structural approaches to HIV prevention: a social ecological perspective. AIDS Care. 2005;17(1):S102-13. (Pubitemid 40979481)
54. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item short-form health survey (SF-36) II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-63.
55. Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J Gen Intern Med. 2009;24(2):189-97.
56. Harrison A, O'Sullivan LF, Hoffman S, Dolezal C, Morrell R. Gender role and relationship norms among young adults in South Africa: measuring the context of masculinity and HIV risk. J Urban Health. 2006;83(4):709-22. (Pubitemid 44337032)
57. Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav. 2011;15(6):1111-20.
58. Weiser S, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S. Routine HIV testing in Botswana: a population based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3:e261.
59. Genberg BL, Kawichai S, Chingono A, Sendah M, Chariyalertsak S, Konda KA, et al. Assessing HIV/AIDS stigma and discrimination in developing countries. AIDS Behav. 2008; 12(5):772-80.
60. Holzemer WL, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini PS, et al. A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007;58(6):541-51.
61. Gielen AC, McDonnell KA, Wu AW, O'Campo P, Faden R. Quality of life among women living with HIV: the importance violence, social support, and self care behaviors. Soc Sci Med. 2001;52(2):315-22.
62. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658-65. (Pubitemid 46763738)
63. Cohen CR, Montandon M, Carrico AW, Shiboski S, Bostrom A, Obure A, et al. Association of attitudes and beliefs towards antiretroviral therapy with HIV-seroprevalence in the general population of Kisumu, Kenya. PLoS One. 2009;4(3):e4573.
64. Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, Busza J, et al. From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc. 2009;12(1):31.
65. Anyango B. personal communication. Kisumu: Tuungane Health Center; 2009.
66. Menya P. Personal communication. Kisumu: Liverpool VCT; 2009.
67. Musili P. Personal communication. Eldoret: AMPATH; 2009.
68. Adeneye AK, Adewole TA, Musa AZ, Onwujekwe D, Odunukwe NN, Araoyinbo ID, et al. Limitations to access and use of antiretroviral therapy (ART) among HIV positive persons in Lagos, Nigeria. World Health Popul. 2006;8(2):46-56.
69. Nyanzi-Wakholi B, Lara AM, Watera C, Munderi P, Gilks C, Grosskurth H. The role of HIV testing, counselling, and treatment in coping with HIV/AIDS in Uganda: a qualitative analysis. AIDS Care. 2009;21(7):903-8.
70. Lertpiriyasuwat C, Yachompoo C, Yuktanon P, Thanprasertsuk S, Leusaree T, Khemngern P, et al., editors. Access to antiretroviral drugs in northern Thailand: perspectives of persons living with HIV/AIDS. Bangkok: XV International AIDS Conference; 2004.
71. Efuntoye M, Okonkwo O, Omorgeie G, Musa G. Increasing access to HIV counselling and testing: a demonstration project trialling the greater involvement of people living with HIV/AIDS (GIPA) in the workplace." Abstract TUZX0405. Mexico: XVII International AIDS Conference; 2008.
72. Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, et al. Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial. PLoS One. 2010; 5(6):e10923.
73. Mukherjee J, Leandre F, Lambert W, editors. Excellent outcomes, high retention in treatment, and low rate of switch to second line ART in community based HIV treatment program in Haiti. Mexico: XVII International AIDS conference Mexico; 2008.
74. Kabore I, Bloem J, Etheredge G, Obiero W, Wanless S, Doykos P, et al. The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in sub-Saharan Africa. AIDS Patient Care STDS. 2010;24(9):581-94.
75. Cabral HJ, Tobias C, Rajabiun S, Sohler N, Cunningham C, Wong M, et al. Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care STDS. 2007;21(1): S59-S67.
76. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;4(19(4)):423-31. (Pubitemid 40446189)
77. Bradford JB, Coleman S, Cunningham W. HIV system navigation: an emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21(1):S49-S58.
78. Louis C, Ivers LC, Smith Fawzi MC, Freedberg KA, Castro A. Late presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care. 2007;19(4):487-91. (Pubitemid 46598753)
79. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;1(52(2)):280-9.
80. Fonck K, Mwai C, Ndinya-Achola J, Bwayo J, Temmerman M. Health-seeking and sexual behaviors among primary healthcare patients in Nairobi, Kenya. Sex Transm Dis. 2002;29(2):106-11. (Pubitemid 34163707)
81. Taegtmeyer M, Kilonzo N, Mung'ala L, Morgan G, Theobald S. Using gender analysis to build voluntary counselling and testing responses in Kenya. Trans R Soc Trop Med Hyg. 2006;100(4): 305-11. (Pubitemid 43174831)
82. Voeten HA, O'Hara HB, Kusimba J, Otido JM, Ndinya-Achola JO, Bwayo JJ, et al. Gender differences in health care-seeking behavior for sexually transmitted diseases: a population-based study in Nairobi, Kenya. Sex Transm Dis. 2004;31(5):265-72. (Pubitemid 38542654)
83. Luseno WK, Wechsberg WM, Kline TL, Ellerson RM. Health services utilization among South African women living with HIV and reporting sexual and substance-use risk behaviors. AIDS Patient Care STDS. 2010;24(4):257-64.
84. Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, et al. Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ. 2009;87(4):279-87.
85. Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12(5): 687-94. (Pubitemid 46625297)
86. Smith R, Carrico A, Montadon M, Bailey R, Kwena Z, Bukusi E, et al. Attitudes and beliefs about antiretroviral therapy are associated with risky sexual behavior in Kisumu, Kenya. 6th annual Conference on Retroviruses and Opportunistic Infectional. Montreal: 2009;Feb. 8-10.
87. Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20(2):146-9. (Pubitemid 351651266)
88. Stevens W, Kaye S, Corrah T. Antiretroviral therapy in Africa. BMJ. 2004;31(328(7434)):280-2. (Pubitemid 38168143)
89. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et al. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. J Acquir Immune Defic Syndr. 2009;1(52(3)):397- 405.
90. Olley BO, Seedat S, Stein DJ. Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health. 2004;8(2):71-6.
91. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M. Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001; 13(5):595-603. (Pubitemid 32928067)
92. Emusu D, Ivankova N, Jolly P, Kirby R, Foushee H, Wabwire- Mangen F, et al. Experience of sexual violence among women in HIV discordant unions after voluntary HIV counselling and testing: a qualitative critical incident study in Uganda. AIDS Care. 2009;21(11):1363-70.
93. Mlay R, Lugina H, Becker S. Couple counselling and testing for HIV at antenatal clinics: views from men, women and counsellors. AIDS Care. 2008;20(3):356-60. (Pubitemid 351451244)
94. Martin-Herz SP, Shetty AK, Bassett MT, Ley C, Mhazo M, Moyo S, et al. Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe. Int J STD AIDS. 2006;17(12): 835-41. (Pubitemid 46057743)
95. Pool R, Nyanzi S, Whitworth JA. Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care. 2001;13(5):605-15. (Pubitemid 32928068)
96. Gielen AC, McDonnell KA, Burke JG, O'Campo P. Women's lives after an HIV-positive diagnosis: disclosure and violence. Matern Child Health J. 2000;4(2):111-20.
97. Grinstead OA, Gregorich SE, Choi KH, Coates T. Positive and negative life events after counselling and testing: the Voluntary HIV-1 counselling and testing efficacy study. AIDS. 2001;25 (15(8)):1045-52. (Pubitemid 32476672)
98. Kilewo C, Massawe A, Lyamuya E, Semali I, Kalokola F, Urassa E, et al. HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2001;15(28(5)):458-62. (Pubitemid 34033198)
99. Maman S, Mbwambo JK, Hogan NM, Kilonzo GP, Campbell JC, Weiss E, et al. HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. Am J Public Health. 2002;92(8):1331-7. (Pubitemid 34815800)
100. Makoae LN, Greeff M, Phetlhu RD, Uys LR, Naidoo JR, Kohi TW, et al. Coping with HIV-related stigma in five African countries. J Assoc Nurses AIDS Care. 2008;19(2):137-46.
101. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIVstatus to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 2008;67(2):301-10. (Pubitemid 351790720)
102. Ogden J, Nyblade L. Common at its core: HIV-related stigma across contexts. Washington: International Center for Research on Women. 2005.
103. Reis C, Heisler M, Amowitz L. Discriminatory attitudes and practices by health workers toward patients with HIV/AIDS in Nigeria. PLoS Med. 2005;2(8):e246.
104. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in Southwestern Uganda: a qualitative study. AIDS Behav. 2009;14(4):778-84. 13.
105. Assefa Y, Van Damme W, Mariam DH, Kloos H. Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS. 2010;24(8):521-5.
106. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010;15(1):43-7.
107. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pretreatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.
108. Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010;1(54(1)):35-41.
109. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization. 2008.
110. Kairania R, Gray RH, Kiwanuka N, Makumbi F, Sewankambo NK, Serwadda D, et al. Disclosure of HIV results among discordant couples in Rakai, Uganda: a facilitated couple counselling approach. AIDS Care. 2010;22(9):1041-51.
111. Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr. 2004;15(375):1620-6. (Pubitemid 39658204)